Health Net
Hemlibra (emicizumab-kxwh)
Drugs for the Blood : Drugs for the Blood
  • Step Therapy: Hemophilia A (Factor VIII):
    ST Single Brand

  • Hemophilia A (Factor VIII):
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Hematologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)
    Dosing Limit(s): Unspecified
    Diagnosis Type(s): Unspecified
    Diagnosis Treatments: Routine propylaxis
    Treatment Center Required: No

    Hemophilia A or B with Inhibitor:
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Hematologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)
    Dosing Limit(s): <= 3
    Diagnosis Type(s): Unspecified
    Diagnosis Treatments: 1 of Bleeding episodes;Routine propylaxis
    Treatment Center Required: No
    Dosing Limits Exist: No

  • Prior Authorization: Hemophilia A (Factor VIII):
    Documented Diagnosis: Yes
    Duration: 6 Month(s)
    Reauthorization Required: Yes

    Hemophilia A or B with Inhibitor:
    PA Applies